tiprankstipranks
Trending News
More News >
Integrum AB Class B (DE:6Y1)
:6Y1

Integrum AB Class B (6Y1) Price & Analysis

Compare
0 Followers

6Y1 Stock Chart & Stats


Financials

6Y1 FAQ

What was Integrum AB Class B’s price range in the past 12 months?
Integrum AB Class B lowest stock price was €1.15 and its highest was €5.14 in the past 12 months.
    What is Integrum AB Class B’s market cap?
    Integrum AB Class B’s market cap is €39.33M.
      When is Integrum AB Class B’s upcoming earnings report date?
      Integrum AB Class B’s upcoming earnings report date is Sep 01, 2025 which is in 82 days.
        How were Integrum AB Class B’s earnings last quarter?
        Integrum AB Class B released its earnings results on Jun 03, 2025. The company reported -€0.04 earnings per share for the quarter, missing the consensus estimate of -€0.027 by -€0.013.
          Is Integrum AB Class B overvalued?
          According to Wall Street analysts Integrum AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Integrum AB Class B pay dividends?
            Integrum AB Class B does not currently pay dividends.
            What is Integrum AB Class B’s EPS estimate?
            Integrum AB Class B’s EPS estimate is -0.01.
              How many shares outstanding does Integrum AB Class B have?
              Integrum AB Class B has 20,694,328 shares outstanding.
                What happened to Integrum AB Class B’s price movement after its last earnings report?
                Integrum AB Class B reported an EPS of -€0.04 in its last earnings report, missing expectations of -€0.027. Following the earnings report the stock price went up 10.968%.
                  Which hedge fund is a major shareholder of Integrum AB Class B?
                  Currently, no hedge funds are holding shares in DE:6Y1

                  Company Description

                  Integrum AB Class B

                  Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Q-linea AB
                  Acarix AB
                  BrainCool AB
                  Doxa AB
                  Mentice AB
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis